Abstract
The type 2 diabetes mellitus (T2DM) has become a serious and growing public health problem, affecting both developed and developing countries. Installation is associated with obesity and insulin resistance. Liraglutide represents a class of injectable drugs for the treatment of T2DM known as incretino-mimetic which exhibit similar effects to human incretin hormone called glucagon-like pep…